Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing the Use of Aspirin for the Prevention of Preeclampsia

NCT07665853 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT07665853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07665853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing the Use of Aspirin for the Prevention of Preeclampsia
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Phase 3
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
May 31, 2028
Enrollment
15,160 (estimated)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia